Best Biopharma Outsourcing Companies in Durham, United States
The 43 best Biopharma Outsourcing companies in Durham, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Avista Pharma.
Our analysis of 50 Biopharma Outsourcing companies
$6.3b in tracked funding; 77% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Durham
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Avista Pharma Leading hosting automation software providing web server and website management tools | $252M | — | Acquired | — | 2015 | — | — | — |
| 2 | Patheon Global CDMO providing integrated drug development, clinical trials, and manufacturing services | $141M | 56 mo ago | Acquired | Doug Sprague Founder | 1974 | Adobe Experience ManagerJavaMicrosoft ASP.NET+14 | 10 patents pH‑dependent solid dosage forms for controlled release of poorly soluble ionizable drugs | — |
| 3 | KBI Biopharma Provider of protein formulation, process & cell line development, and cGMP services | $21M | 204 mo ago | Acquired | — | 1996 | HubSpot CMS HubApple iCloud MailMicrosoft 365+26 | 24 patents Non‑chromatographic polypeptide purification and fluidized‑bed particle manipulation technologies. | 1 launch · 1 partnership |
| 4 | Cutting Edge Info Research reports and data provider for pharmaceutical and life science industries | $16M | 230 mo ago | Series A | Jason Richardson Co-Founder and CEO | 2002 | — | — | — |
| 5 | Zen-Bio Cell-based solutions for drug discovery, research, and cosmetic development | $10M | 179 mo ago | Acquired | — | 1995 | Cart FunctionalityExpertRecPHP+10 | — | — |
| 6 | Isolere Bio Developer of bioprocessing reagents for purification and manufacturing of therapeutics | $7M | 54 mo ago | Acquired | Joseph McMahon Co-Founder | 2017 | Cart FunctionalitySquarespace CommerceSquarespace+15 | — | — |
| 7 | QATCH Technologies CRO focused on providing early stage drug development services | $6M | 17 mo ago | Funding Raised | — | 2016 | — | — | 1 launch |
| 8 | AlphaVax RNA particle vaccine technology company developing anti-infective and anti-cancer vaccines | $3M | 195 mo ago | Funding Raised | — | 1997 | — | 159 patents Production of alphavirus replicon particles for vaccine and gene‑therapy vectors | — |
| 9 | Lamassu Pharma Provider of market research and clinical development & testing services | $3M | 29 mo ago | Seed | Greg Palmer Co-Founder & CSO | 2018 | — | — | — |
| 10 | Health Decisions CRO focused on clinical trial services for data management, monitoring and biostatistics | $2M | 100 mo ago | Acquired | — | 1989 | — | — | — |
| 11 | Sciome Provider of software development services for biopharma sector | $2M | 35 mo ago | Funding Raised | — | 2010 | — | 9 patents AI-powered text extraction and recall estimation for scientific literature mining | — |
| 12 | VeraSci Provider of data management and site selection services | $1M | 120 mo ago | Acquired | — | 2016 | — | — | — |
| 13 | Premier Research Provider of clinical trial CRO services | $200K | 118 mo ago | Public | — | 1989 | WordPress Block EditorWordPressApple iCloud Mail+36 | — | — |
Top 12 Biopharma Outsourcing companies in Durham
#1
Funding Raised · Durham, North Carolina · founded 2016 · 6 employees$5.6Mraised▾
QATCH Technologies is a life-science instrumentation start-up, and was founded to commercialize a sensor technology developed at Duke University. QATCH is currently developing a tool to prescreen injectability and manufacturability of biopharmaceutical drugs at an early stage of drug development due to the very low volume needed (μLs). QATCH's proprietary technology can de-risk preclinical phase for biopharmaceutical drug development and prevent delays for crucial medicines reaching patients.
- Mar 2025Grant (prize money)$1.5M
- Sep 2023Grant (prize money)$1.9M
- Feb 2022Grant (prize money)$1.5M
- Sep 2020Grant (prize money)$255.7K
#2
Acquired · Durham, North Carolina · founded 1974 · 9000 employees$141Mraised▾
Global CDMO providing integrated drug development, clinical trials, and manufacturing services. They offer comprehensive contract development and manufacturing organization (CDMO) and contract research organization (CRO) solutions to accelerate drug development journeys. Their capabilities span small and large molecules, advanced therapies like viral vectors, cell therapy, and mRNA, and steriles. Services include clinical trial services, clinical packaging, labeling, logistics, and commercial services. They focus on innovative solutions, digital enablement, and supply chain strategies for risk mitigation. They provide end-to-end solutions across all phases of development, from early-stage R&D to commercial manufacturing, with a global network of sites and scientific expertise. They aim to simplify and accelerate the journey to market, offering integrated offerings and digital platforms for collaboration and transparency.
#3
Seed · Durham, North Carolina · founded 2018 · 3 employees$2.7Mraised▾
Provider of market research and clinical development & testing services
- Mar 2024Grant (prize money)$2M
- Jul 2020Grant (prize money)$1.5M
- Jul 2020Grant (prize money)$2.5M
- Apr 2020Seed$2.7M
#4
Acquired · Durham, North Carolina · founded 2015 · 330 employees$252Mraised▾
Leading hosting automation software providing web server and website management tools. It offers a comprehensive and user-friendly GUI designed to help IT specialists efficiently manage web, DNS, mail, and other essential services. This software simplifies the complexities of web hosting, providing secure and simple solutions for managing web servers and websites. It is a hosting control panel that empowers users to create domains and set up web hosting with ease. The platform offers a knowledge base, developer blog, and forum to support its users. It is a B2B tech company offering software solutions.
#5
Funding Raised · Durham, North Carolina · founded 2010$1.5Mraised▾
Provider of software development services for biopharma sector
- Sep 2023Grant (prize money)$249.9K
- Aug 2018Grant (prize money)$225K
- Sep 2017Grant (prize money)$1M
#6
Acquired · Durham, North Carolina · founded 2017 · 18 employees$7Mraised▾
Developer of bioprocessing reagents for purification and manufacturing of therapeutics. The company provides reagents designed for affinity and phase separation to improve manufacturability. These reagents aim to harness the power of phase separation with affinity ligands. The reagents target specific biomolecules and enable concentration, washing, dissociation, and collection of final products.
- Feb 2022Grant (prize money)$255.6K
- Sep 2021Grant (prize money)$255.5K
- May 2021Seed$7M
- May 2021Grant (prize money)$892.7K
#7
Acquired · Durham, North Carolina · founded 1996 · 1243 employees$21Mraised▾
Provider of protein formulation, process & cell line development, and cGMP services
- Aug 2009Series A$9.6M
- Feb 2009Series A$7.4M
- Sep 2008Unattributed$1.3M
- Jan 2005Convertible Debt$2.7M
#8
Acquired · Durham, North Carolina · founded 1995 · 21 employees$10.4Mraised▾
Cell-based solutions for drug discovery, research, and cosmetic development. They provide human and animal cells, media, and related systems for effective discovery research. Their offerings include blood/serum products, cell/tissue-derived products, cell culture media, and various cell types. They specialize in custom culture services, procurement solutions, and cell-based assay development. They offer research kits for cosmeceutical applications, including anti-cellulite and anti-wrinkle treatments. They also provide technical support, manuals, and other resources. Their services extend to contract research, cell characterization, and molecular biology. They focus on delivering robust cell-based solutions to accelerate the discovery and development of therapies and cosmetic applications.
- Sep 2011Grant (prize money)$350.7K
- Aug 2011Grant (prize money)$251.1K
- Oct 2010Grant (prize money)$1.9M
- Sep 2010Grant (prize money)$1.3M
#9
Series A · Durham, North Carolina · founded 2002 · 25 employees$15.8Mraised▾
Cutting Edge Info is a company that provides decision-making support for pharmaceutical and other life science companies. Provides reports, customised research, and benchmarking data. Provides off-the-shelf and customised research for key areas including medical affairs, clinical development, managed markets strategy, pharmacovigilance, marketing management, sales and field force management, payer relationship management, lifecycle management, patient education, market research, staffing, and budgeting, benchmarking and competitive intelligence. The company's clientele includes Merck, Mylan, Novartis, Amgen, Abbott, AbbVie, Bayer, Celgene and AstraZeneca.
- Jun 2007Series A$15.8M
#10
Funding Raised · Durham, North Carolina · founded 1997 · 9 employees$3Mraised▾
RNA particle vaccine technology company developing anti-infective and anti-cancer vaccines. The company focuses on redefining vaccines and their role in medicine through its proprietary alphavaccine RNA particle vector platform technology. This technology is used to generate vaccine candidates for infectious disease prevention and cancer immunotherapy. The company's approach involves engaging the patient’s immune system to recognize and fight off various cancers. The alphavaccine technology is based on an RNA replicon vector platform derived from attenuated strains of the alphavirus, Venezuelan equine encephalitis (VEE) virus. The company's corporate strategy includes out-licensing its alphavaccine technology for specific disease and/or antigen applications for commercialization.
- May 2010Grant (prize money)$135.2K
- Aug 2008Grant (prize money)$1M
- Jul 2007Grant (prize money)$1.8M
#11
Acquired · Durham, North Carolina · founded 1989 · 110 employees$1.8Mraised▾
CRO focused on clinical trial services for data management, monitoring and biostatistics
- Apr 2018Unattributed$1.8M
#12
Acquired · Durham, North Carolina · founded 2016 · 181 employees$1.4Mraised▾
Provider of data management and site selection services
- Aug 2016Grant (prize money)—
- May 2016Grant (prize money)$1.4M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in the United States
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 6,260 United States-affiliated papers.
- Harvard University209
- Cornell University177
- University of Tennessee at Chattanooga140
- Howard Hughes Medical Institute126
- Johns Hopkins University121
- Gene33→164
- Transcription (linguistics)11→79
- Antibody11→62
- Genome6→56
- Mutation7→56
- Gene8→110
- Cell culture3→62
- Gene expression3→62
- Fermentation2→54
- Downregulation and upregulation1→50
- Agriculture19→58
- Antibiotic resistance15→45
- Public health4→31
- Gene6→30
- Production (economics)5→29
Where biotechnology is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in the United States
United States biotechnology patent filing is accelerating — 457,918 filings from 8,000 assignees (2016–2025), led by Genentech, UNIV California, Regeneron Pharma; annual filings 36884→44446.
- Genentech18078
- UNIV California17948
- Regeneron Pharma16082
- Amgen10495
- Monsanto Technology9742
- UNIV Pennsylvania8521
- Harvard College7460
- UNIV Texas7378
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.